NO20084632L - Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syre - Google Patents

Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syre

Info

Publication number
NO20084632L
NO20084632L NO20084632A NO20084632A NO20084632L NO 20084632 L NO20084632 L NO 20084632L NO 20084632 A NO20084632 A NO 20084632A NO 20084632 A NO20084632 A NO 20084632A NO 20084632 L NO20084632 L NO 20084632L
Authority
NO
Norway
Prior art keywords
hydroxybenzoyl
cyclopentyloxy
hydroxy
propionic acid
benzisoxazol
Prior art date
Application number
NO20084632A
Other languages
English (en)
Norwegian (no)
Inventor
Yukie Tada
Kenji Yonezawa
Hironori Kotsubo
Yasutaka Baba
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NO20084632L publication Critical patent/NO20084632L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20084632A 2006-05-26 2008-11-04 Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syre NO20084632L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006146220 2006-05-26
PCT/JP2007/060670 WO2007138996A1 (ja) 2006-05-26 2007-05-25 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸の新規な結晶

Publications (1)

Publication Number Publication Date
NO20084632L true NO20084632L (no) 2008-12-12

Family

ID=38778516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084632A NO20084632L (no) 2006-05-26 2008-11-04 Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syre

Country Status (27)

Country Link
US (1) US7977492B2 (hr)
EP (1) EP2022788B1 (hr)
JP (1) JP5117381B2 (hr)
KR (1) KR101389038B1 (hr)
CN (1) CN101454298B (hr)
AT (1) ATE479666T1 (hr)
AU (1) AU2007268771B2 (hr)
BR (1) BRPI0712909A2 (hr)
CA (1) CA2652939C (hr)
CY (1) CY1111398T1 (hr)
DE (1) DE602007008882D1 (hr)
DK (1) DK2022788T3 (hr)
EC (1) ECSP089000A (hr)
ES (1) ES2351065T3 (hr)
HR (1) HRP20100544T1 (hr)
IL (1) IL195416A (hr)
MA (1) MA30510B1 (hr)
MX (1) MX2008014906A (hr)
NO (1) NO20084632L (hr)
NZ (1) NZ573034A (hr)
PL (1) PL2022788T3 (hr)
PT (1) PT2022788E (hr)
RS (1) RS51517B (hr)
RU (1) RU2429233C2 (hr)
SI (1) SI2022788T1 (hr)
WO (1) WO2007138996A1 (hr)
ZA (1) ZA200809922B (hr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ593062A (en) * 2006-02-21 2012-04-27 Toyama Chemical Co Ltd Process for production of 3-[5-[4-cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process
DK2258361T3 (da) * 2008-03-27 2014-10-27 Toyama Chemical Co Ltd ANVENDELSE AF ET BENZOPHENONDERIVAT ELLER ET SALT DERAF I KOMBINATION MED EN TNFalfa-INHIBITOR OG FARMACEUTISK SAMMENSÆTNING INDEHOLDENDE DERIVATET ELLER SALTET DERAF OG INHIBITOREN
WO2009131098A1 (ja) 2008-04-22 2009-10-29 富山化学工業株式会社 ベンゾフェノン誘導体またはその塩および免疫抑制剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物
CN103183647B (zh) * 2011-12-28 2017-06-09 天津市国际生物医药联合研究院有限公司 3‑{[2‑[3‑氧‑(1,2‑苯并异噻唑‑6‑基)甲氧基‑5‑(2‑羟基‑4‑环戊氧基苯甲酰基)]苯基}丙酸的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042150A (en) 1960-01-26 1962-07-03 Lukawsky Michael Emergency brake and anti-skid device
AU7083894A (en) * 1993-07-06 1995-02-06 Yamanouchi Pharmaceutical Co., Ltd. Novel crystal of benzodiazepine derivative
EP1127869A4 (en) 1998-11-05 2007-05-02 Toyama Chemical Co Ltd NOVEL COMPOUNDS AND THEIR MEDICAL USE
JP4976617B2 (ja) 2000-03-17 2012-07-18 富山化学工業株式会社 新規なベンゾフェノン誘導体およびその塩
BR0214177A (pt) 2001-11-16 2004-09-14 Toyama Chemical Co Ltd Derivado de benzofenona, agente preventivo ou terapêutico para uma doença em que está envolvida expressão excessiva de ap-1, e, inibidor de ap-1

Also Published As

Publication number Publication date
KR20090014194A (ko) 2009-02-06
HRP20100544T1 (hr) 2010-11-30
CN101454298A (zh) 2009-06-10
WO2007138996A1 (ja) 2007-12-06
EP2022788B1 (en) 2010-09-01
ZA200809922B (en) 2010-02-24
ATE479666T1 (de) 2010-09-15
SI2022788T1 (sl) 2011-01-31
ECSP089000A (es) 2009-02-27
CA2652939A1 (en) 2007-12-06
JP5117381B2 (ja) 2013-01-16
PL2022788T3 (pl) 2011-03-31
RS51517B (en) 2011-06-30
MX2008014906A (es) 2008-12-09
MA30510B1 (fr) 2009-06-01
JPWO2007138996A1 (ja) 2009-10-08
RU2008151778A (ru) 2010-07-10
EP2022788A1 (en) 2009-02-11
US7977492B2 (en) 2011-07-12
RU2429233C2 (ru) 2011-09-20
CN101454298B (zh) 2011-11-16
AU2007268771B2 (en) 2011-12-01
EP2022788A4 (en) 2009-06-24
PT2022788E (pt) 2010-10-04
IL195416A (en) 2012-07-31
CA2652939C (en) 2014-12-02
CY1111398T1 (el) 2015-08-05
DK2022788T3 (da) 2010-12-13
KR101389038B1 (ko) 2014-04-28
NZ573034A (en) 2010-08-27
US20090275757A1 (en) 2009-11-05
BRPI0712909A2 (pt) 2012-10-02
AU2007268771A1 (en) 2007-12-06
IL195416A0 (en) 2009-08-03
ES2351065T3 (es) 2011-01-31
DE602007008882D1 (de) 2010-10-14

Similar Documents

Publication Publication Date Title
NO20084632L (no) Nye krystaller av 3-[5-[4-(cyclopentyloksy)-2-hydroksybenzoyl]-2-[(3-hydroksy-1,2-benzisoksazol-6-yl)metoksy]-fenyl]propion syre
EA201300231A1 (ru) Способ проектирования инкрементального счетчика доз для ингалятора, компьютерный способ его проектирования и способ их серийного производства
AR117778A2 (es) Forma sólida de un naftaleno carboxamida
NO20065973L (no) Injeksjonsinnretning
NO20085328L (no) Deksel for injeksjonsanordning
WO2005034952A3 (en) Isoxazole and isothiazole compounds useful in the treatment of inflammation
ATE471313T1 (de) 3,5-di(aryl - oder heteroaryl) isoxazole und 1,2, 4-oxadiazole als s1p1-rezeptoragonisten, das immunsystem unterdrückende und entzündungshemmende mittel
WO2010036506A3 (en) Interchangable access device for a dispenser
FR2967344B1 (fr) Dispositif pour l'injection d'un ciment osseux comprenant un systeme de blocage de sur-pression
WO2008126657A1 (ja) Dmaコントローラ
WO2008009924A3 (en) Indoles useful in the treatment of inflammation
ATE500899T1 (de) Austragvorrichtung für medien
RS20050036A (en) Synergistically acting herbicidal mixtures
NO20100363L (no) Rotasjonsmekanisme
UA102539C2 (ru) Производные оксадиазола, активные в отношении сфингозин-1-фосфата (s1p)
WO2012036384A3 (ko) 낚시용 릴의 브러쉬 브레이크장치
ATE518935T1 (de) Optisch isotropes flüssigkristallmedium und optische vorrichtung
PE20080554A1 (es) Formulacion acuosa del acido 4-[((4-carboxibutil)-{2-[(4-fenetilbencil)oxi]fenil}amino)metil]benzoico
WO2013134552A3 (en) Cordless spray device
BRPI0606178A2 (pt) derivados de 3-aril-1,2-benzisoxazol e sua utilização como medicamentos contra o cáncer
TW200745227A (en) Polymer film, polarizing plate protective film, polarizing plate and liquid crystal display device
WO2009069643A1 (ja) 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸またはその塩を含有する固体分散体またはその組成物
Ting et al. Nonlinear Hysteresis Control System
Jankiewicz et al. A Triradical Cation: Reactivity Studies of the 2, 4, 6-Tridehydropyridinium Ion
Fu et al. The Influences of Craft Parameter on Ti and NdFeB Films Configuration